ENTRY       D10579            Mixture   Drug
NAME        Conjugated estrogens and bazedoxifene acetate;
            Oestrogens conjugated with bazedoxifene acetate;
            Duavee (TN);
            Duavive (TN)
PRODUCT     DUAVEE (U.S. Pharmaceuticals)
            DUAVEE (Wyeth Pharmaceuticals LLC)
COMPONENT   Conjugated estrogens [DR:D04070], Bazedoxifene acetate [DR:D03062]
REMARK      ATC code: G03CC07
            Product: D10579<US>
EFFICACY    Osteoporosis agent
  DISEASE   Osteoporosis [DS:H01593]
COMMENT     Prevention of postmenopausal osteoporosis
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
               G03C ESTROGENS
                G03CC Estrogens, combinations with other drugs
                 G03CC07 Conjugated estrogens and bazedoxifene
                  D10579  Conjugated estrogens and bazedoxifene acetate &lt;US&gt;
            USP drug classification [BR:br08302]
             Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
              Selective Estrogen Receptor Modifying Agents
               Conjugated Estrogens/ Bazedoxifene
                D10579  Conjugated estrogens and bazedoxifene acetate
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10579
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10579
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10579
DBLINKS     PubChem: 254741541
///
